Abstract:Introduction: C-reactive protein circulates as a pentameric protein (pCRP). pCRP is a well-established diagnostic marker as plasma levels rise in response to tissue injury and inflammation. We recently described pro-inflammatory properties of CRP, which are mediated by conformational changes from pCRP to bioactive isoforms expressing pro-inflammatory neo-epitopes [pCRP* and monomeric C-reactive protein (mCRP)]. Here, we investigate the role of CRP isoforms in renal ischemia/reperfusion injury (IRI).Methods: Rat kidneys in animals with and without intraperitoneally injected pCRP were subjected to IRI by the time of pCRP exposure and were subsequently analyzed for monocyte infiltration, caspase-3 expression, and tubular damage. Blood urea nitrogen (BUN) was analyzed pre-ischemia and post-reperfusion. CRP effects on leukocyte recruitment were investigated via intravital imaging of rat-striated muscle IRI. Localized conformational CRP changes were analyzed by immunohistochemistry using conformation specific antibodies. 1,6-bis(phosphocholine)-hexane (1,6-bisPC), which stabilizes CRP in its native pentameric form was used to validate CRP effects. Leukocyte activation was assessed by quantification of reactive oxygen species (ROS) induction by CRP isoforms ex vivo and in vitro through electron spin resonance spectroscopy. Signaling pathways were analyzed by disrupting lipid rafts with nystatin and subsequent ROS detection. In order to confirm the translational relevance of our findings, biopsies of microsurgical human free tissue transfers before and after IRI were examined by immunofluorescence for CRP deposition and co-localization of CD68+ leukocytes.Results: The application of pCRP aggravates tissue damage in renal IRI. 1,6-bisPC reverses these effects via inhibition of the conformational change that leads to exposure of pro-inflammatory epitopes in CRP (pCRP* and mCRP). Structurally altered CRP induces leukocyte-endothelial interaction and induces ROS formation in leukocytes, the latter can be abrogated by blocking lipid raft-dependent signaling pathways with Nystatin. Stabilizing pCRP in its native pentameric state abrogates these pro-inflammatory effects. Importantly, these findings are confirmed in human IRI challenged muscle tissue.Conclusion: These results suggest that CRP is a potent modulator of IRI. Stabilizing the native pCRP conformation represents a promising anti-inflammatory therapeutic strategy by attenuation of leukocyte recruitment and ROS formation, the primary pathomechanisms of IRI.

C-Reactive Protein-Derived Peptide 201-206 Inhibits Neutrophil Adhesion To Endothelial Cells And Platelets Through Cd32

The C‐terminal Hexapeptide in C‐reactive Protein Inhibits Neutrophil Adhesion to Endothelial Cells Through CD32

Receptor for Advanced Glycation End Products Involved in Circulating Endothelial Cells Release from Human Coronary Endothelial Cells Induced by C-reactive Protein

Monomeric C-Reactive Protein Activates Endothelial Cells Via Interaction with Lipid Raft Microdomains

A cell attachment peptide from human C-reactive protein

High-Density Lipoproteins Neutralize C-Reactive Protein Proinflammatory Activity

Neutrophil CD16b Crosslinking Induces Lipid Raft-Mediated Activation of SHP-2 and Affects Cytokine Expression and Retarded Neutrophil Apoptosis

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

mCRP-Induced Focal Adhesion Kinase-Dependent Monocyte Aggregation and M1 Polarization, Which Was Partially Blocked by the C10M Inhibitor

A Redox Switch in C-reactive Protein Modulates Activation of Endothelial Cells.

The Role of C-reactive Protein in Innate and Acquired Inflammation: New Perspectives

Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions

Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo

C-Reactive Protein in Atherothrombosis and Angiogenesis

C-reactive Protein and Inflammation: Conformational Changes Affect Function

A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury

Regulation of Conformational Changes in C-reactive Protein Alters Its Bioactivity

The effect of human C-reactive protein on the cell-attachment activity of fibronectin and laminin

Monomeric C-reactive protein: A novel biomarker predicting neurodegenerative disease and vascular dysfunction

C‐reactive protein inhibits endothelium‐dependent prostacyclin synthase‐mediated dilation of coronary arterioles: role of peroxynitrite

A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation